Trademark: 86753205
Word

Status
Registered
Status Code
702
Status Date
Monday, September 18, 2023
Serial Number
86753205
Registration Number
5172332
Registration Date
Tuesday, March 28, 2017
Mark Type
2000
Filing Date
Thursday, September 10, 2015
Published for Opposition
Tuesday, June 21, 2016

Trademark Owner History
Biologics Consulting Group, Inc. - Original Registrant

Classifications
35 Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; regulatory submission management, namely, assisting others in preparing and filing applications for new medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology with governmental regulatory bodies around the world; regulatory submission management, namely, providing simultaneous multiple country submissions of applications for the registration and approval of medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology; providing information online regarding regulatory submission management; business management consulting, strategic planning and business advisory services provided to medical, medical technology, biopharmaceutical, and biotechnology companies, and government agencies, educational and research institutions, law firms, and investment firms in the fields of biologics, pharmaceuticals and medical devices; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for drug and medical device approval; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs and medical devices with governmental regulatory bodies; business consulting services in the field of biologics, pharmaceuticals, prescription drugs and medical devices
45 Regulatory compliance consulting services, namely, reviewing standards and practices to assist clients with compliance with governmental laws, regulations and rules in the fields of medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology; providing technical regulatory affair consulting services directed to medical, medical technology, biopharmaceutical, and biotechnology companies in order to assure compliance with food and drug administration's laws and regulations; provision of information online pertaining to regulatory compliance in the fields of medical devices, medical technologies, medications, biopharmaceuticals, and biotechnology; and regulatory compliance consulting in the fields of biologics, pharmaceuticals, prescription drugs and medical devices
42 Consulting services for others in the field of designing pre-clinical and clinical studies and trials for others; product research and development for others in the fields of biologics, pharmaceuticals, prescription drugs and medical devices; quality management services, namely, quality evaluation and analysis, quality assurance and quality control in the field of biologics, pharmaceuticals, prescription drugs and medical devices; scientific consulting and research services relating to the field of pharmaceuticals, medical devices, and life sciences, namely, biology, and medicine; consulting services in the fields of biotechnology and pharmaceuticals, namely, design, development, technical verification and technical validation of manufacturing and filling processes, drug formulations, testing protocols and analytical methods; and scientific and technological services, namely, scientific research, analysis, testing, and related scientific studies in the field of chemistry and molecular biology, namely, biologics and protein detection, characterization, analysis and testing; consulting services in the field of medical device product approval for commercial purposes
The mark consists of 11 circles connected by single lines forming 2 connected polygons.
Color is not claimed as a feature of the mark.

Trademark Events
Sep 18, 2023
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Sep 18, 2023
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Sep 18, 2023
Case Assigned To Post Registration Paralegal
Mar 16, 2023
Teas Section 8 & 15 Received
Mar 28, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Mar 28, 2017
Registered-Principal Register
Feb 22, 2017
Notice Of Acceptance Of Statement Of Use E-Mailed
Feb 21, 2017
Allowed Principal Register - Sou Accepted
Feb 3, 2017
Statement Of Use Processing Complete
Jan 16, 2017
Use Amendment Filed
Feb 3, 2017
Case Assigned To Intent To Use Paralegal
Jan 16, 2017
Teas Statement Of Use Received
Aug 16, 2016
Noa E-Mailed - Sou Required From Applicant
Jun 21, 2016
Official Gazette Publication Confirmation E-Mailed
Jun 21, 2016
Published For Opposition
Jun 1, 2016
Notification Of Notice Of Publication E-Mailed
May 18, 2016
Approved For Pub - Principal Register
May 18, 2016
Examiner's Amendment Entered
May 18, 2016
Notification Of Examiners Amendment E-Mailed
May 18, 2016
Examiners Amendment E-Mailed
May 18, 2016
Examiners Amendment -Written
Jan 5, 2016
Notification Of Non-Final Action E-Mailed
Jan 5, 2016
Non-Final Action E-Mailed
Jan 5, 2016
Non-Final Action Written
Dec 22, 2015
Assigned To Examiner
Sep 16, 2015
Notice Of Design Search Code E-Mailed
Sep 15, 2015
New Application Office Supplied Data Entered
Sep 14, 2015
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24